Abiopharma

🔍 Frangou Angeliki (Executive)

Company: Navios Maritime Partners L.P. (NMM)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 1,195 shares of Common Unit at $69.2232 per share (Direct)
  Date: 2026-06-26 | Code: P | equity_swap_involved: false | shares_owned_after: 4,756,211.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Acquired 1,208 shares of Common Unit at $68.8774 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 4,757,419.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
• Acquired 1,199 shares of Common Unit at $69.5013 per share (Direct)
  Date: 2026-06-30 | Code: P | equity_swap_involved: false | shares_owned_after: 4,758,618.00 | transaction_form_type: 4 | Footnotes: F1, F2, F5
• Holds 0 shares of Common Unit (Direct)
  Date: 2026-06-26 | Code: H | shares_owned_after: 366,776.00
• Holds 0 shares of General Partnership Unit (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 622,296.00 | Footnotes: F6

Footnotes:

• F1: The transactions reported herein were made pursuant to a Rule 10b5-1 trading plan between Raymar Investments S.A., an entity affiliated with Ms. Frangou, and UBS Financial Services Inc. adopted on December 9, 2025.
• F2: The transactions reported herein were effected in multiple transactions each day at prices ranging from (1) $68.59 to $69.88 on June 26, 2026; (2) $68.01 to $69.75 on June 29, 2026; and (3) $69.09 to $69.87 on June 30, 2026. The prices reported above reflect the weighted average purchase prices on each such day for the transactions reported herein. The Reporting Person hereby undertakes to provide upon request to the Staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer full information regarding the number of shares and the prices at which these reported transactions were effected each day.
• F3: The number of common units beneficially owned by Ms. Frangou includes (i) 3,183,199 common units owned indirectly through N Shipmanagement Acquisition Corp., an entity affiliated with her; (ii) 1,489,115 common units in the aggregate owned indirectly through three other entities affiliated with her and (iii) 83,897 common units owned through Raymar Investments S.A., an entity affiliated with Ms. Frangou, pursuant to a Rule 10b5-1 trading plan with UBS Financial Services Inc as of June 26, 2026.
• F4: The number of common units beneficially owned by Ms. Frangou includes (i) 3,183,199 common units owned indirectly through N Shipmanagement Acquisition Corp., an entity affiliated with her; (ii) 1,489,115 common units in the aggregate owned indirectly through three other entities affiliated with her and (iii) 85,105 common units owned through Raymar Investments S.A., an entity affiliated with Ms. Frangou, pursuant to a Rule 10b5-1 trading plan with UBS Financial Services Inc as of June 29, 2026.
• F5: The number of common units beneficially owned by Ms. Frangou includes (i) 3,183,199 common units owned indirectly through N Shipmanagement Acquisition Corp., an entity affiliated with her; (ii) 1,489,115 common units in the aggregate owned indirectly through three other entities affiliated with her and (iii) 86,304 common units owned through Raymar Investments S.A., an entity affiliated with Ms. Frangou, pursuant to a Rule 10b5-1 trading plan with UBS Financial Services Inc as of June 30, 2026.
• F6: Olympos Maritime Ltd., an entity affiliated with Ms. Frangou, is the general partner (the "General Partner") of Navios Maritime Partners L.P. ("NMM"). As of June 30, 2026, the General Partner owns 622,296 general partnership units, representing an approximately 2.1% ownership interest in NMM based on all outstanding common units and general partnership units.
• REMARKS: Chief Executive Officer & Chairwoman of the Board